Immunology and failure of valved allografts in children

Annals of Thoracic Surgery

Volumn 74, Issue 4, 2002, Pages 1271-1275

  Shaddy, Robert E ^a,b   Hawkins, John A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY;

AGE; ALLOGRAFT; ANTIBODY RESPONSE; BLOOD GROUP ABO INCOMPATIBILITY; CELL VIABILITY; CONFERENCE PAPER; CONGENITAL HEART DISEASE; GRAFT FAILURE; GRAFT SURVIVAL; HEART VALVE BIOPROSTHESIS; HEART VALVE STENOSIS; HISTOINCOMPATIBILITY; HLA MATCHING; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; OPEN HEART SURGERY; PRIORITY JOURNAL; RISK FACTOR; TREATMENT INDICATION;

ABO BLOOD-GROUP SYSTEM; AGE FACTORS; CHILD; CRYOPRESERVATION; GRAFT REJECTION; HEART DEFECTS, CONGENITAL; HEART VALVES; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036798923     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)03885-7     Document Type: Conference Paper

References (53)

1. Baskett RJ, Ross DB, Nanton MA, Murphy DA. Factors in the early failure of cryopreserved homograft pulmonary valves in children: preserved immunogenicity? J Thorac Cardiovasc Surg 1996;112:1170-9.
2. Tweddell JS, Pelech AN, Frommelt PC, et al. Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation 2000;102(Suppl 3):III130.
3. Niwaya K, Knott-Craig CJ, Lane MM, et al. Cryopreserved homograft valves in the pulmonary position: risk analysis for intermediate-term failure. J Thorac Cardiovasc Surg 1999; 117:141-7.
4. Bull C, Macartney FJ, Horvath P, et al. Evaluation of long-term results of homograft and heterograft valves in extracardiac conduits. J Thorac Cardiovasc Surg 1987;94:12-9.
5. Motomura N, Imakita M, Yutani C, et al. Histological change in cryopreserved rat aortic allograft. J Cardiovasc Surg (Torino) 1995;36:53-60.
6. Green MK, Walsh MD, Dare A, et al. Histologic and immunohistochemical responses after aortic valve allografts in the rat. Ann Thorac Surg 1998;66(Suppl):S216.
7. Moustapha A, Ross DB, Bittira B, et al. Aortic valve grafts in the rat: evidence for rejection. J Thorac Cardiovasc Surg 1997;114:891-902.
8. Crescenzo DG, Hilbert SL, Barrick MK, et al. Donor heart valves: electron microscopic and morphometric assessment of cellular injury induced by warm ischemia. J Thorac Cardiovasc Surg 1992;103:253-8.
9. Ross DN. Evolution of the homograft valve. Ann Thorac Surg 1995;59:565-7.
10. McNally RT, Brockbank KG. The correlation between improved cellular viability and clinical performance in 5,000 cryopreserved human heart valves. ASAIO Trans 1991;37:M355-6.
11. Niwaya K, Sakaguchi H, Kawachi K, Kitamura S. Effect of warm ischemia and cryopreservation on cell viability of human allograft valves. Ann Thorac Surg 1995;60(Suppl):S114.
12. Gall KL, Smith SE, Willmette CA, O'Brien MF. Allograft heart valve viability and valve-processing variables. Ann Thorac Surg 1998;65:1032-8.
13. Johnson DL, Sloan C, O'Halloran A, Yacoub MH. Effect of antibiotic pretreatment on immunogenicity of human heart valves and component cells. Ann Thorac Surg 1998;66(Suppl):S221.
14. Motomura N, Imakita M, Yutani C, et al. Histologic modification by cryopreservation in rat aortic allografts. Ann Thorac Surg 1995;60(Suppl):S168.
15. Cochran RP, Kunzelman KS. Cryopreservation does not alter antigenic expression of aortic allografts. J Surg Res 1989;46:597-9.
16. Lupinetti FM, Tsai TT, Kneebone JM, Bove EL. Effect of cryopreservation on the presence of endothelial cells on human valve allografts. J Thorac Cardiovasc Surg 1993;106:912-7.
17. Armiger LC. Postimplantation leaflet cellularity of valve allografts: are donor cells beneficial or detrimental? Ann Thorac Surg 1998;66(Suppl):S233.
18. Kneebone JM, Lupinetti FM. Procollagen synthesis by fresh and cryopreserved rat pulmonary valve grafts. J Thorac Cardiovasc Surg 2000;120:596-603.
19. O'Brien MF, Stafford EG, Gardner MA, et al. A comparison of aortic valve replacement with viable cryopreserved and fresh allograft valves, with a note on chromosomal studies. J Thorac Cardiovasc Surg 1987;94:812-23.
20. Mitchell RN, Jonas RA, Schoen FJ. Structure-function correlations in cryopreserved allograft cardiac valves. Ann Thorac Surg 1995;60(Suppl):S108.
21. Mitchell RN, Jonas RA, Schoen FJ. Pathology of explanted cryopreserved allograft heart valves: comparison with aortic valves from orthotopic heart transplants. J Thorac Cardiovasc Surg 1998;115:118-27.
22. Rajani B, Mee RB, Ratliff NB. Evidence for rejection of homograft cardiac valves in infants. J Thorac Cardiovasc Surg 1998;115:111-7.
23. Vogt PR, Stallmach T, Niederhauser U, et al. Explanted cryopreserved allografts: a morphological and immunohistochemical comparison between arterial allografts and allograft heart valves from infants and adults. Eur J Cardiothorac Surg 1999;15:639-45.
24. Wagner E, Roy R, Marois Y, et al. Fresh venous allografts in peripheral arterial reconstruction in dogs. Effects of histocompatibility and of short-term immunosuppression with cyclosporine A and mycophenolate mofetil. J Thorac Cardiovasc Surg 1995;110:1732-44.
25. Legare JF, Issekutz T, Lee TD, Hirsch G. CD8+ T lymphocytes mediate destruction of the vascular media in a model of chronic rejection. Am J Pathol 2000;157:859-65.
26. Hawkins JA, Bailey WW, Dillon T, Schwartz DC. Midterm results with cryopreserved allograft valved conduits from the right ventricle to the pulmonary arteries. J Thorac Cardiovasc Surg 1992;104:910-6.
27. Clarke DR, Campbell DN, Hayward AR, Bishop DA. Degeneration of aortic valve allografts in young recipients. J Thorac Cardiovasc Surg 1993;105:934-42.
28. Yankah AC, Alexi-Meskhishvili V, Weng Y, et al. Accelerated degeneration of allografts in the first two years of life. Ann Thorac Surg 1995;60(Suppl):S71.
29. Shaddy RE, Hunter DD, Osborn KA, et al. Prospective analysis of HLA immunogenicity of cryopreserved valved allografts used in pediatric heart surgery. Circulation 1996;94:1063-7.
30. Welters MJ, Oei FB, Vaessen LM, et al. Increased numbers of circulating donor-specific T helper lymphocytes after human heart valve transplantation. Clin Exp Immunol 2001;124: 353-8.
31. Shaddy RE, Tani LY, Sturtevant JE, et al. Effects of homograft blood type and anatomic type on stenosis, regurgitation and calcium in homografts in the pulmonary position. Am J Cardiol 1992;70:392-3.
32. Kadner A, Chen RH, Mitchell RN, Adams DH. Hemograft crossmatching is unnecessary due to the absence of blood group antigens. Ann Thorac Surg 2001;71(Suppl):S349.
33. Fischlein T, Schutz A, Haushofer M, et al. Immunologic reaction and viability of cryopreserved homografts. Ann Thorac Surg 1995;60(Suppl):S122.
34. Hoekstra F, Knoop C, Jutte N, et al. Effect of cryopreservation and HLA-DR matching on the cellular immunogenicity of human cardiac valve allografts. J Heart Lung Transplant 1994;13:1095-8.
35. Hoekstra F, Knoop C, Aghai Z, et al. Stimulation of immunecompetent cells in vitro by human cardiac valve-derived endothelial cells. Ann Thorac Surg 1995;60(Suppl):S131.
36. Hoekstra F, Knoop C, Vaessen L, et al. Donor-specific cellular immune response against human cardiac valve allografts. J Thorac Cardiovasc Surg 1996;112:281-6.
37. Zhao XM, Green M, Frazer IH, et al. Donor-specific immune response after aortic valve allografting in the rat. Ann Thorac Surg 1994;57:1158-63.
38. Wagner E, Roy R, Marois Y, et al. Posttransplant antibodies and fresh venous allograft failure in dogs. Transplantation 1994;58:537-42.
39. Smith JD, Ogino H, Hunt D, et al. Humoral immune response to human aortic valve homografts. Ann Thorac Surg 1995;60(Suppl):S127.
40. Shaddy RE, Thompson DD, Osborne KA, et al. Persistence of human leukocyte antigen (HLA) antibodies after one year in children receiving cryopreserved valved allografts. Am J Cardiol 1997;80:358-9.
41. Hoekstra F, Witvliet M, Knoop C, et al. Donor-specific anti-human leukocyte antigen class I antibodies after implantation of cardiac valve allografts. J Heart Lung Transplant 1997;16:570-2.
42. Breinholt JP III, Hawkins JA, Lambert LM, et al. A prospective analysis of the immunogenicity of cryopreserved nonvalved allografts used in pediatric heart surgery. Circulation 2000;102(Suppl 3):III179.
43. Hoekstra FM, Witvliet M, Knoop CY, et al. Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies. Ann Thorac Surg 1998; 66:2022-6.
44. Oei FB, Welters MJ, Knoop CJ, et al. Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipients. Eur J Cardiothorac Surg 2000;18:466-72.
45. Oei F, Dor F, Stegmann A, et al. Helper T cell frequencies after implantation of aortic valve allografts in rats. Transplant Proc 2001;33:640-1.
46. Legare JF, Ross DB, Issekutz TB, et al. Prevention of allograft heart valve failure in a rat model. J Thorac Cardiovasc Surg 2001;122:310-7.
47. Yankah AC, Wottge HU, Muller-Ruchholtz W. Short-course cyclosporin A therapy for definite allograft valve survival immunosuppression in allograft valve operations. Ann Thorac Surg 1995;60(Suppl):S146.
48. Bechtel JF, Bartels C, Schmidtke C, et al. Does histocompatibility affect homograft valve function after the Ross procedure? Circulation 2001;104(Suppl 1):I25.
49. Elkins RC, Lane MM, Capps SB, et al. Humoral immune response to allograft valve tissue pretreated with an antigen reduction process. Semin Thorac Cardiovasc Surg 2001; 13(Suppl 1):82.
50. Steinhoff G, Stock U, Karim N, et al. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation 2000; 102(Suppl 3):III50.
51. Schmitz-Rixen T, Megerman J, Colvin RB, et al. Immunosuppressive treatment of aortic allografts. J Vasc Surg 1988; 7:82-92.
52. Vischjager M, Van Gulik TM, De Kleine RH, et al. Experimental arterial allografting under low and therapeutic dosages of cyclosporine for immunosuppression. Transplantation 1996;61:1138-42.
53. Shaddy RE, Lambert LM, Fuller TC, et al. Prospective randomized trial of azathioprine in cryopreserved valved allografts in children. Ann Thorac Surg 2001;71:43-8.